News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Japan
Business
Boehringer, Sosei Ink Potential $732M Deal for Schizophrenia Treatment
Boehringer Ingelheim has paid $27.3 million upfront to Sosei Heptares to develop a small molecule agonist of GPR52 to treat the positive, negative and cognitive symptoms of schizophrenia.
March 11, 2024
·
2 min read
·
Tyler Patchen
PRESS RELEASES
Press Releases
Otsuka Pharmaceutical to Acquire Transcend Therapeutics
March 27, 2026
·
8 min read
Press Releases
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
March 27, 2026
·
14 min read
Press Releases
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
March 26, 2026
·
7 min read
Press Releases
BostonGene Demonstrates Disease Modeling Platform at JSMO 2026, Advancing AI-Driven Drug Development and Precision Oncology
March 26, 2026
·
3 min read
Press Releases
Fujitsu and The University of Osaka develop new technologies for chemical material energy calculations on early-FTQC quantum computers
March 25, 2026
·
2 min read
Press Releases
EpiFrontier Therapeutics Secures up to $32M Grant from the Japan Agency for Medical Research and Development to Advance Novel Therapy for Beta Globin Disorders
March 24, 2026
·
6 min read
Press Releases
KIFFIK Biomedical and HekaBio Announce Strategic Alliance to Expand ISF-Based Molecular Access Across Asia-Pacific
March 24, 2026
·
3 min read
Press Releases
Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
March 24, 2026
·
24 min read
Press Releases
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
March 24, 2026
·
15 min read
Press Releases
Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older
March 24, 2026
·
8 min read
Press Releases
Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)
March 23, 2026
·
8 min read
Press Releases
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026
March 22, 2026
·
16 min read
Press Releases
Two Leaders in Pathology Innovation: Sakura Finetek and Hamamatsu Photonics K.K. Announce Global Alliance
March 20, 2026
·
3 min read
Press Releases
Shionogi Announces First Patients Enrolled in Global Phase 2 Clinical Trial in Adults with Late-Onset Pompe Disease
March 19, 2026
·
8 min read
Press Releases
AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors
March 18, 2026
·
4 min read
Press Releases
Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan
March 17, 2026
·
3 min read
Press Releases
Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G Nfl Blood Assay
March 17, 2026
·
2 min read
Press Releases
Otsuka Unveils New Repinatrabit Open-Label Extension Data in Phenylketonuria (PKU) Signaling Efficacy in Adolescents at the 2026 American College of Medical Genetics and Genomics (ACMG) Meeting
March 13, 2026
·
8 min read
Press Releases
Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti-PD-1 Agonist Antibody Discovered Through Collaborative Research With FBRI
March 12, 2026
·
3 min read
Press Releases
Precision for Medicine Continues Asia-Pacific Expansion with Opening of Japan Office
March 11, 2026
·
3 min read
